Although high expression of KDM1A has been shown to promote malignant behaviors [9] and predict poor survivals for patients with ESCC [10], it is still unclear whether and how it remodels the TME to drive the oncogenic processes in ESCC. This evidence concerns the gene KDM1A and esophageal squamous cell carcinoma.